Previous 10 | Next 10 |
home / stock / zldpf / zldpf news
Company announcement - No. 22 / 2018 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, September 14, 2018 - Zealand Pharma A/S ("Zealand") (NASDAQ: ZEAL), a Copenhagen-based biotechnology company focused on the discovery and d...
Press release - No. 19 / 2018 Zealand Pharma to attend J.P. Morgan Cazenove and Morgan Stanley Global Healthcare Conferences Copenhagen, September 7, 2018 - Mats Blom, Executive Vice President and Chief Financial Officer (CFO) of Zealand Pharma, will attend the J.P. Morgan Caz...
Company announcement - No. 21/ 2018 Zealand sells royalty streams and milestones for USD 205 million to Royalty Pharma Copenhagen, September 6, 2018 - Zealand Pharma A/S ("Zealand") (NASDAQ: ZEAL), a Copenhagen-based biotechnology company focused on the discovery and developme...
The following slide deck was published by Zealand Pharma A/S in conjunction with their 2018 Q2 earnings Read more ...
Zealand Pharma ( OTCPK:ZLDPF ): Q2 EPS of -DKK4.18 More news on: Zealand Pharma A/S, Zealand Pharma, Earnings news and commentary, Read more ...
Company announcement - No. 20 / 2018 Zealand Pharma - Interim report for the first half of 2018 Copenhagen, August 16, 2018 - Zealand Pharma A/S ("Zealand") (Company reg. No. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery, design a...
Press Release - No. 18 / 2018 Zealand hosts conference call on August 16 at 4 pm CET/10 am EDT to present first half of 2018 results Copenhagen, August 13, 2018 - Zealand Pharma A/S ("Zealand") (CVR no. 20 04 50 78) announces that it will be hosting a conference cal...
Company announcement - No. 19/2018 Zealand announces an 85% increase in Soliqua ® 100/33/ Suliqua® royalty revenue from first to second quarter of 2018 Net sales of Soliqua ® 100/33/ Suliqua® and Lyxumia®/Adlyxin® of DKK 171 million/USD 27 ...
Company announcement - No.18/ 2018 Zealand Pharma major shareholder announcement: Van Herk Investments Copenhagen, July 11, 2018 - Zealand Pharma announces that it today has received the following major shareholder notification: As at 10 July 2018 Van Herk Investments B.V. (Du...
Press Release - No. 17/2018 Zealand Pharma presents two dasiglucagon milestone studies at the 78th Scientific Sessions of the American Diabetes Association (ADA) Low doses of dasiglucagon effectively counteract low blood glucose in people with type 1 diabetes Long-t...
News, Short Squeeze, Breakout and More Instantly...
Zealand Pharma A/S Ord Company Name:
ZLDPF Stock Symbol:
OTCMKTS Market:
Zealand Pharma A/S Ord Website:
Company announcement – No. 35 / 2024 Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE U...
Company announcement – No. 34 / 2024 Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO T...
Company announcement – No. 33 / 2024 Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CAN...